Earnings History Data for Medicenna Therapeutics Corp. (MDNA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Medicenna Therapeutics Corp.

Medicenna Therapeutics Corp is a clinical stage immuno-oncology company. It is engaged in developing engineered versions of IL-2, IL4 and IL13 cytokines called Superkines and Empowered Cytokines ECs for the treatment of cancer. Medicenna Therapeutics Corp is based in Toronto, Canada.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-07-2023	PM		MDNA	Medicenna Therapeutics	31.00	-0.04	-0.04	0.00	Medicenna Therapeutics GAAP EPS of -$0.04 [7/28/2023 3:05 PM]	0.4397	0.0 (-0.07%)	0.45	0.01 (2.27%)	0.37 - 1.88	150,715	190,000	10,024
Medicenna Therapeutics GAAP EPS of -$0.04 [7/28/2023 3:05 PM]
27-06-2023	AH	7:00 AM ET (Jun 27)	MDNA	Medicenna Therapeutics	35.00	-0.04	-0.06	0.00	Medicenna Therapeutics GAAP EPS of -$0.16 in-line [6/27/2023 4:08 PM]	0.5445	0.11 (24.43%)	0.45	0.01 (2.83%)	0.40 - 1.88	265,408	80,000	471
Medicenna Therapeutics GAAP EPS of -$0.16 in-line [6/27/2023 4:08 PM]
07-02-2023	PM	7:00 AM ET (Feb 7)	MDNA	Medicenna Therapeutics Corp.	54.31	-0.01	-0.06	-0.07	Medicenna Therapeutics GAAP EPS of -$0.02 beats by $0.05 [2/7/2023 7:33 AM]	0.7585	-0.01 (-0.85%)	0.83	0.06 (8.50%)	0.40 - 2.00	103,712	240,000	7,507
Medicenna Therapeutics GAAP EPS of -$0.02 beats by $0.05 [2/7/2023 7:33 AM]
04-11-2022	PM	7:00 AM ET (Nov 4)	MDNA	Medicenna Therapeutics Corp.	48.75	-0.05	-0.06	-0.12	Medicenna Therapeutics GAAP EPS of -$0.01 beats by $0.05 [11/4/2022 7:25 AM]	0.6470	-0.02 (-3.00%)	0.70	0.03 (4.95%)	0.60 - 2.52	192,258	210,000	8,026
Medicenna Therapeutics GAAP EPS of -$0.01 beats by $0.05 [11/4/2022 7:25 AM] Medicenna Reports Second Quarter Fiscal 2023 Financial Results and Operational Highlights [Nov-04-22 07:00AM]
15-08-2022	PM	7:00 AM ET (Aug 15)	MDNA	Medicenna Therapeutics Corp.	78.83	-0.06	-0.06	-0.10	Medicenna Therapeutics GAAP EPS of -$0.07 in-line [8/15/2022 7:12 AM]	1.00	-0.07 (-6.54%)	1.10	0.03 (2.80%)	0.76 - 2.94	439,896	620,000	1,056
Medicenna Therapeutics GAAP EPS of -$0.07 in-line [8/15/2022 7:12 AM] Medicenna Reports First Quarter Fiscal 2023 Financial Results and Operational Highlights [Aug-15-22 07:00AM]
22-06-2022	PM	7:00 AM ET (Jun 22)	MDNA	Medicenna Therapeutics Corp.	44.35	-0.05	-0.08	-0.09	Medicenna Therapeutics GAAP EPS of -C$0.42 [6/22/2022 7:07 AM]	0.9755	0.13 (15.31%)	0.0	0.0 (0.00%)	0.76 - 3.83	374,960	30,000	0
Medicenna Therapeutics GAAP EPS of -C$0.42 [6/22/2022 7:07 AM] Medicenna Reports Fiscal Year 2022 Financial Results and Operational Highlights [Jun-22-22 07:00AM]
09-02-2022	PM	7:00 AM ET (Feb 9)	MDNA	Medicenna Therapeutics Corp.	92.84	-0.07	-0.11	-0.08	Medicenna Therapeutics GAAP EPS of -$0.09 [2/9/2022 7:18 AM]	1.85	0.0 (0.00%)	0.0	0.0 (0.00%)	1.40 - 4.62	98,404	80,000	0
Medicenna Therapeutics GAAP EPS of -$0.09 [2/9/2022 7:18 AM] Medicenna Reports Third Quarter Fiscal 2022 Financial Results and Operational Highlights [Feb-09-22 07:00AM]
12-11-2021	PM	7:00 AM ET (Nov 12)	MDNA	Medicenna Therapeutics Corp.	105.87	-0.12	-0.09	-0.06	Medicenna Therapeutics reports FQ2 results [11/12/2021 7:06 AM]	2.05	0.02 (0.74%)	2.24	0.21 (10.07%)	1.85 - 6.84	99,693	140,000	5,496
Medicenna Therapeutics reports FQ2 results [11/12/2021 7:06 AM] Medicenna Reports Second Quarter Fiscal 2022 Financial Results and Operational Highlights [Nov-12-21 07:00AM] Great news for Medicenna Therapeutics Corp. (TSE:MDNA): Insiders acquired stock in large numbers last year [Nov-12-21 09:00AM]
13-08-2021	PM	7:30 AM ET (Aug 13)	MDNA	Medicenna Therapeutics Corp.	106.38	-0.10	-0.08	-0.04	Medicenna Therapeutics reports Q1 results [8/13/2021 7:10 AM]	2.06	-0.12 (-5.47%)	2.19	0.01 (0.46%)	2.00 - 6.84	185,330	70,000	122
Medicenna Therapeutics reports Q1 results [8/13/2021 7:10 AM] Medicenna Reports First Quarter Fiscal 2022 Financial Results and Operational Highlights [Aug-13-21 07:00AM]
28-05-2021	PM	7:00 AM ET (May 28)	MDNA	Medicenna Therapeutics Corp.	180.55	-0.09	-0.08	-0.05		3.91	0.09 (2.47%)	3.85	0.03 (0.79%)	3.14 - 6.84	197,482	80,000	300
Medicenna Therapeutics reports FY results [5/28/2021 7:36 AM] Medicenna Reports Fiscal Year 2021 Financial Results and Operational Highlights [May-28-21 07:30AM]
12-02-2021	PM	7:00 AM ET (Feb 12)	MDNA	Medicenna Therapeutics Corp.	206.00	-0.08	-0.06	0.00	Medicenna Therapeutics reports FQ3 results [2/12/2021 7:16 AM]	3.95	-0.16 (-3.94%)	0.0	0.0 (0.00%)	1.46 - 6.84	459,620	182,793	0
Medicenna Therapeutics reports FQ3 results [2/12/2021 7:16 AM]
12-02-2021	PM		MDNA	Medicenna Therapeutics Corp.	200.56	-0.08	-0.05	-0.05	Medicenna Therapeutics reports FQ3 results [2/12/2021 7:16 AM]	4.11	0.04 (0.98%)	4.08	0.01 (0.25%)	1.46 - 6.84	183,418	182,793	5,669
Medicenna Therapeutics reports FQ3 results [2/12/2021 7:16 AM] Medicenna Reports Third Quarter Fiscal 2021 Financial Results and Operational Highlights [Feb-12-21 07:00AM]